Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NovoTTF-200T
- Development stage
- Unknown
- Lead developer
- NovoCure
- Modality
- Device-based Delivery → Drug Delivery Systems
- Administration
- Topical
01
Overview
NovoTTF-200T is a portable, battery-powered, noninvasive medical device that delivers Tumor Treating Fields (TTFields)—low-intensity, alternating electric fields—to disrupt cancer cell division. The device is designed to be used in combination with systemic therapies such as atezolizumab and bevacizumab for the first-line treatment of patients with unresectable or metastatic liver cancer. TTFields therapy works by interfering with the electrically charged components of dividing cancer cells, leading to disruption of mitosis and ultimately inhibiting tumor growth or causing cell death. The system has also been studied in combination with other agents like sorafenib and is under investigation for use in several solid tumors including non-small cell lung cancer (NSCLC), pancreatic cancer, and brain metastases[1][2][4][5][6][7].
- Brand names
- NovoTTF-200TNovoTTF200TNovoTTF 200T
- Other names
- Optune Lua
Beyond the preview
Go deeper on NovoTTF-200T.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NovoTTF-200T.